PRKAA2 and medulloblastoma: Notwithstanding the debate on the nature of the effect (pro- versus anti-tumorigenic) [28,29,30,31,32,33,34], our observation that AMPKα2 impairs tumor progression in the SmoA1 mouse model of medulloblastoma validates this hypothesis.